Molecular Medicine |
From the Department of Medicine, University of Washington, Seattle.
Correspondence to David A. Dichek, MD, Department of Medicine, University of Washington, Box 357710, 1959 NE Pacific St, Seattle, WA 98195-7710. E-mail ddichek{at}u.washington.edu
Transforming growth factor (TGF)-ß1 is a potent stimulator of intimal growth. We showed previously that TGF-ß1 stimulates intimal growth through early upregulation of plasminogen activator inhibitor-1 (PAI-1) and, subsequently, PAI-1dependent increases in cell migration and matrix accumulation. We also showed that PAI-1 negatively regulates TGF-ß1 expression in the artery wall. Here we use plasminogen-deficient mice to test whether TGF-ß1stimulated, PAI-1dependent intimal growth and PAI-1 suppression of TGF-ß1 expression are mediated through inhibition of plasminogen activation by PAI-1. We also use lineage tracing to investigate the origin of cells in TGF-ß1induced intimas. Surprisingly, both TGF-ß1induced, PAI-1dependent intimal growth and PAI-1 suppression of TGF-ß1 expression are independent of plasminogen. Moreover, approximately 50% of cells that migrate into the intima of TGF-ß1overexpressing arteries carry a smooth muscle lineage marker, <1% carry a bone marrow lineage marker, and the remaining cells carry neither marker. Therefore, PAI-1 stimulates intimal growth and suppresses TGF-ß1 expression through activities other than inhibition of plasminogen activation. In addition, contrary to widely held models, our results do not support a role for plasmin (or thrombospondin) in TGF-ß1 activation in the artery wall. Further identification of the molecular targets through which PAI-1 stimulates intimal formation and suppresses TGF-ß1 expression in the artery wall may reveal new approaches for inhibiting intimal formation. Our studies also discount bone marrow as an important source from which TGF-ß1 recruits intimal cells and suggest instead that TGF-ß1 induces substantial cell migration either from the adventitia or from an extravascular, but nonhematopoietic source.
Key Words: plasminogen activator inhibitor-1 plasminogen transforming growth factor ß1 intima
This article has been cited by other articles:
![]() |
M. Kremen, R. Krishnan, I. Emery, J. H. Hu, K. I. Slezicki, A. Wu, K. Qian, L. Du, A. Plawman, A. Stempien-Otero, et al. Plasminogen mediates the atherogenic effects of macrophage-expressed urokinase and accelerates atherosclerosis in apoE-knockout mice PNAS, November 4, 2008; 105(44): 17109 - 17114. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N Artaza, R. Singh, M. G Ferrini, M. Braga, J. Tsao, and N. F Gonzalez-Cadavid Myostatin promotes a fibrotic phenotypic switch in multipotent C3H 10T1/2 cells without affecting their differentiation into myofibroblasts J. Endocrinol., February 1, 2008; 196(2): 235 - 249. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |